Purchase Order 75D30119P06295

This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Bioreliance Corporation, a foreign-owned, for-profit organization, for $89,113.67. The contract is for LINE ITEM 3: CELL CULTURE IDENTIFICATION (380801.BSV) services. Bioreliance Corporation, through its Life Sciences Services Division, provides specialized testing services to support investigational new drug applications,...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $231,000.00 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for the provision of EXPI293F license and cell lines. This contract does not have a set-aside designation. The products and services are to be delivered by the July 31, 2021 completion date. Life Technologies Corporation is a subsidiary of the parent company Thermo Electron Corporation, which...

This is a $93,300.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Cisbio US, Inc., a foreign-owned for-profit company, for the provision of 10,000 HISTONE2 HTRF Assay test kits. The award was not set aside. Cisbio US, Inc. has previously provided assay kits, cell lines, and collagen reagents related to disease research to various Department of Health and Human Services (HHS) agencies, including the NIH, Centers for Disease Control and...

This federal contract award is for the provision of custom reagents for a Homogeneous Time-Resolved Fluorescence (HTRF) assay, with a ceiling value of $18,700.00. The contract was awarded to Cisbio US, Inc., a foreign-owned for-profit organization that provides assay kits and reagents to the U.S. federal government, particularly the Department of Health and Human Services (HHS) and its agencies such as the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and...

This is a firm-fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Bioreliance Corporation, a foreign-owned, for-profit organization, for the storage of Vero and MDCK cells in liquid nitrogen under compliant Good Manufacturing Practice (cGMP) and compliant Good Laboratory Practice (cGLP) conditions. The contract has a ceiling value of $131,226.00 and a period of performance ending on May 31, 2026. The contract was awarded on a sole-source basis, as the...

The Centers for Disease Control and Prevention (CDC) awarded a $249,662 purchase order to Cell Microsystems Inc. to procure cell lines in support of the agency's biomedical research and public health initiatives. The firm fixed price contract has a period of performance from September 11, 2023 through October 30, 2023 for delivery of the requested cell lines to CDC facilities in Durham, North Carolina. No subcontractors or set aside designations were identified. This award advances the CDC's...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed-price purchase order valued at $20,787.00 to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for the provision of the PATHHUNTER CHO-K1 DRD2L (LONG ISOFORM) ARRESTIN cell line, which is used in drug discovery and development research. Eurofins Discoverx is a leading provider of innovative cell-based...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract to Genscript USA Inc., a for-profit biotechnology company, for stable cell line development services with a completion date of April 1, 2020. The contract had a potential value of $130,400.99 and was not set aside for any particular business type. Genscript provides a range of molecular biology products and services, including gene synthesis, gene editing,...

This is a $99,715.40 firm fixed-price purchase order awarded to Cisbio US, Inc., a foreign-owned for-profit company, by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The contract is for the provision of assay kits, cell lines, and collagen reagents to support research activities. This award was not set aside and is the latest in a series of similar purchase orders awarded to Cisbio US, Inc. to provide biomarker...

Cell Sciences, Inc. was awarded a $4,681 purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development to provide unspecified products or services in Bethesda, Maryland. The firm fixed price contract runs from September 10, 2014 through November 30, 2014. No additional details were provided regarding the original solicitation or work to be performed. Cell Sciences, Inc. will serve as the prime contractor on...